Decentralised Clinical Trial (DCT) Master Class: Equip your studies for digital success in 2022

November 22, 2022 | 11 CET

Space is limited. Reserve now.

This master class is for sponsors or biotech professionals who want to become certified experts in hybrid and decentralised clinical trial (DCT) design.

By the end of the class, you'll be able to: 

• Convey critical elements and best practices for implementing DCTs for customers
• Implement best practices for digital strategies in studies
• Explain how DCTs operate at both the site and patient levels
• Improve patient enrollment, engagement, and retention 
• Reduce overall delivery timelines and costs
• Share your DCT certification badge to your social media accounts (i.e., LinkedIn, Twitter) and add it to your email signature
  

Plus, learn firsthand what Tufts CSDD's new report says about decreases in clinical trial cycle times, screen failure rates, and substantive protocol elements that help drive:

• Phase II studies - Possible net benefits up to 5x greater than the upfront investment required.
• Phase III studies - Possible net benefits up to 13x greater than the upfront investment required.
  

Join Medable's Vice President & General Manager Andrew Mackinnon, and Senior Director Business Development Chris Tutill, for what will surely be an engaging and informative master class.

‍Learn from the No. 1 DCT provider in the industry!